Reporter

The Conversation

Latest News

Novavax COVID vaccine is nearing approval – but what impact will it have?

The pandemic has been rumbling on for two years and is probably going to rumble on for years to come. And despite recent excitement about new drugs to treat COVID, it’s still vaccines that will underpin each country’s route out of the pandemic.
By The Conversation

Calling children ‘vectors’ during COVID-19 is turning into discrimination

During the COVID-19 pandemic children have been the target of dehumanising language and of policy which prioritises the needs of adults over theirs.
By The Conversation

Brexit deal done: what’s in it and where next for the UK and EU?

To misquote Shakespeare, our Brexit negotiating revels now are ended. The tempestuous talks did not lead to a dramatic walkout, even if at times the UK government gave the impression this was a feud worthy of the Montagues against the Capulets. The negotiators ignored the background noise and succeeded in drafting a dense legal document on which the future of UK-EU relations now hangs.
By The Conversation

top Business stories, straight to your inbox.

How to prepare and protect your gut health over Christmas and the silly season

Gut health matters. Your gut is a crucial part your immune system. In fact, 70% of your entire immune system sits around your gut, and an important part of that is what’s known as the gut-associated lymphoid tissue (GALT), which houses a host of immune cells in your gut.
By The Conversation

Can Queen Elizabeth save Christmas?

The Queen shares personal anecdotes, which she often links to ordinary people’s experiences through the pronouns “we” and “us”.
By The Conversation

Obama book offers key insight about how laws really get made

Amid all the attention on former President Barack Obama’s new book, what may not have shown up in the reviews is mention of a two-page summary that, for legislative scholars like me, includes what may be the shortest and perhaps best description of how legislatures really work, even for political scientists.
By The Conversation

Why eco-labelling is so difficult during the COVID-19 pandemic

The eco-labels we come to trust are often ones backed by credible audits that involve in-person inspections of production facilities to check that environmental and ethical claims are real.
By The Conversation

New antidepressants can lift depression and suicidal thoughts fast, but don’t expect magic cures

Depression is the most common cause of disability in the world. Chances are high that you or someone you know will experience a period when depression gets in the way of work, social life or family life. Nearly two in three people with depression will experience severe effects.
By The Conversation

The coronavirus vaccine: A doctor answers 5 questions

Here, Dr. Jason McKnight, a primary care physician at Texas A&M University, answers five questions about the rollout and distribution underway.
By The Conversation

COVID-19 further exposes inequalities in the global financial system

To stem the economic fallout from COVID-19, developed countries have injected an unprecedented US$9 trillion into their economies.
By The Conversation

Armenians displaced from Nagorno-Karabakh fear their medieval churches will be destroyed

A six-week war in Nagorno-Karabakh, a mountainous region in the South Caucasus, ended on Nov. 9 after Russia brokered a peace deal between Armenia and Azerbaijan.
By The Conversation

Pardon me? An ethicist’s guide to what is proper when it comes to presidential pardons

Questions surrounding President Trump’s use of the pardon power began almost as soon as he entered office in 2017 and will continue undoubtedly through his final days in power.
By The Conversation